Back
United Therapeutics Stock Price Chart

The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
58
UTHR
United Therapeutics
Last Price:
$314.18
Seasonality Move:
3.89%
7 Day Trial
ALL ACCESS PASS
$
7

Your Data Made Them Billions-Now It's Your Turn to Profit
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UTHR is experiencing buying pressure, which is a positive indicator for future bullish movement.
United Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 310.15 | Buy |
20-day SMA: | 332.11 | Sell |
50-day SMA: | 349.3 | Sell |
200-day SMA: | 343.81 | Sell |
8-day EMA: | 313.79 | Buy |
20-day EMA: | 325.8 | Sell |
50-day EMA: | 342.55 | Sell |
200-day EMA: | 334.46 | Sell |
United Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -13.16 | Sell |
Relative Strength Index (14 RSI): | 45.53 | Sell |
Chaikin Money Flow: | 348466 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (309.97 - 363.11) | Sell |
Bollinger Bands (100): | (337.96 - 382) | Sell |
United Therapeutics Technical Analysis
Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for United Therapeutics Stock
Is United Therapeutics Stock a Buy?
-
United Therapeutics share price is 322.94 while UTHR 8-day simple moving average is 310.15, which is a Buy signal.
-
The stock price of UTHR is 322.94 while United Therapeutics 20-day SMA is 332.11, which makes it a Sell.
-
United Therapeutics 50-day simple moving average is 349.30 while UTHR share price is 322.94, making it a Sell technically.
-
UTHR stock price is 322.94 and United Therapeutics 200-day simple moving average is 343.81, creating a Sell signal.
UTHR Technical Analysis vs Fundamental Analysis
Buy
58
United Therapeutics (UTHR)
is a Buy
Is United Therapeutics a Buy or a Sell?
-
United Therapeutics stock is rated a BuyThe current United Therapeutics [UTHR] share price is $322.94. The Score for UTHR is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
United Therapeutics Stock Info
Market Cap:
14.5B
Price in USD:
322.94
Share Volume:
400.6K
United Therapeutics 52-Week Range
52-Week High:
417.82
52-Week Low:
221.53
Buy
58
United Therapeutics (UTHR)
is a Buy
United Therapeutics Share Price Forecast
-
What is the United Therapeutics stock price today?The United Therapeutics stock price is 322.94 USD today.
-
Will UTHR stock go up or go down?United Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is United Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, United Therapeutics is not overvalued.
Is United Therapeutics Stock a Buy?
-
United Therapeutics share price is 322.94 while UTHR 8-day exponential moving average is 313.79, which is a Buy signal.
-
The stock price of UTHR is 322.94 while United Therapeutics 20-day EMA is 325.80, which makes it a Sell.
-
United Therapeutics 50-day exponential moving average is 342.55 while UTHR share price is 322.94, making it a Sell technically.
-
UTHR stock price is 322.94 and United Therapeutics 200-day simple moving average is 334.46, creating a Sell signal.
Fundamental Analysis of United Therapeutics
Is United Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.78 per share, a decrease next quarter of $0.81 per share, an increase this year of $2.78 per share, and an increase next year of $0.04 per share.
Technical Analysis of United Therapeutics
Should I short United Therapeutics stock?
-
UTHR Moving Average Covergence Divergence (MACD) indicator is -13.16, suggesting United Therapeutics is a Sell
-
United Therapeutics Relative Strength Index (RSI) is 45.53, which suggest United Therapeutics is oversold
-
The Bollinger Bands (25) for United Therapeutics is (309.97 - 363.11), which suggest United Therapeutics is a Sell
-
The Bollinger Bands (100) for United Therapeutics is (337.96 - 382), which suggest United Therapeutics is a Sell
* United Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.